Bacterial Infections  >>  Nuvocid (oritavancin)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nuvocid (oritavancin) / Melinta Therap, Menarini
NCT02925416: Safety of Either a Single or Two Intravenous Doses of Orbactiv in Participants With Acute Bacterial Skin and Skin Structure Infection

Completed
4
22
US
Oritavancin, Orbactiv, Placebo (D5W)
The Medicines Company
Skin Diseases, Bacterial
06/17
06/17

Download Options